載入中
NASDAQHealthcareMedical - Diagnostics & Research
最新資料
US$1.13
+US$0.04 · +3.67%
iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, biobanks, and blood centers. The company develops and manages iSpecimen Marketplace, an innovative online hub that strategically links medical researchers requiring access to subjects, samples, and pertinent data with organizations that hold these invaluable resources. iSpecimen's clientele primarily includes biopharmaceutical firms, in vitro diagnostics companies, and governmental and academic research institutions. The company, established in 2009, is headquartered in Lexington, Massachusetts.
前收盤價
US$1.13
+US$0.04 · +3.67%
盤中時間採用ET。市場資料可能有所延遲。
iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, biobanks, and blood centers. The company develops and manages iSpecimen Marketplace, an innovative online hub that strategically links medical researchers requiring access to subjects, samples, and pertinent data with organizations that hold these invaluable resources. iSpecimen's clientele primarily includes biopharmaceutical firms, in vitro diagnostics companies, and governmental and academic research institutions. The company, established in 2009, is headquartered in Lexington, Massachusetts.
日內區間
目前US$1.13
52週區間
目前US$1.13
盤中時間採用ET。市場資料可能有所延遲。
GoAI 評分
賣出
估值
16
估值過高
情緒
52
多空交錯
風險
74
高風險
動能
17
強勢下行
完整 GoAI 研究
繼續查看更深入的依據、催化因素和風險。
iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, biobanks, and blood centers. The company develops and manages iSpecimen Marketplace, an innovative online hub that strategically links medical researchers requiring access to subjects, samples, and pertinent data with organizations that hold these invaluable resources. iSpecimen's clientele primarily includes biopharmaceutical firms, in vitro diagnostics companies, and governmental and academic research institutions. The company, established in 2009, is headquartered in Lexington, Massachusetts.
日內區間
目前US$1.13
52週區間
目前US$1.13
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 192.9萬 USD | 929.11萬 USD | 992.82萬 USD | 1040.23萬 USD | 1113.53萬 USD |
| 銷貨成本 | 190.49萬 USD | 530.27萬 USD | 482.03萬 USD | 475.7萬 USD | 524.9萬 USD |
| 毛利 | 2.41萬 USD | 398.84萬 USD | 510.79萬 USD | 564.53萬 USD | 588.63萬 USD |
| 研究與開發 | 215.98萬 USD | 353.03萬 USD | 356.69萬 USD | 265.63萬 USD | 183.79萬 USD |
| 銷售、一般及管理費用 | 659.52萬 USD | 1264.83萬 USD | 1167.99萬 USD | 1237.4萬 USD | 939.97萬 USD |
| 營業費用 | 900.2萬 USD | 1671.64萬 USD | 1627.73萬 USD | 1583.14萬 USD | 1181.15萬 USD |
| 利息收入 | 3748 USD | 4.41萬 USD | 33.98萬 USD | 16.93萬 USD | 1.14萬 USD |
| 利息支出 | 1949 USD | 22.01萬 USD | 23.08萬 USD | 23.9萬 USD | 210.27萬 USD |
| 折舊和攤銷 | 173.09萬 USD | 229.42萬 USD | 211.51萬 USD | 120.52萬 USD | 100.4萬 USD |
| 營業利益 | −897.79萬 USD | −1272.8萬 USD | −1116.93萬 USD | −1018.61萬 USD | −592.52萬 USD |
| 淨利 | −1048.75萬 USD | −1249.78萬 USD | −1109.95萬 USD | −1024.59萬 USD | −896.18萬 USD |
公司資料更新於 2026年10月12日。
近期已公布業績
近期已公布業績
| 行動 | 生效日期 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股票分割 | 2026年4月28日 | 1:40 | — | — |
股票分割 | 2024年9月16日 | 1:20 | — | — |
已生效 2026年4月28日
1:40
已生效 2024年9月16日
1:20
報告持有此股票曝險的交易所交易基金。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
